Modelling and drug screening for cardiovascular disease

R. Passier

doi:10.1111/apha.12866

Modelling and drug screening for cardiovascular disease

R. Passier

Applied Stem Cell Technologies

Research output: Contribution to journal › Special issue › Academic › peer-review

1 Downloads (Pure)

Abstract

Special Issue:
Abstracts of the 96th Annual Meeting of the German Physiological Society, 16–18 March 2017, Greifswald, Germany

Original language	English
Article number	SO2-2
Pages (from-to)	7-7
Journal	Acta physiologica
Volume	219
Issue number	S711
DOIs	https://doi.org/10.1111/apha.12866
Publication status	Published - Mar 2017

Access to Document

10.1111/apha.12866

Cite this

@article{bc74e683a0f64dd29715e7489e6d34a9,

title = "Modelling and drug screening for cardiovascular disease",

abstract = "Special Issue:Abstracts of the 96th Annual Meeting of the German Physiological Society, 16–18 March 2017, Greifswald, Germany ",

author = "R. Passier",

year = "2017",

month = mar,

doi = "10.1111/apha.12866",

language = "English",

volume = "219",

pages = "7--7",

journal = "Acta physiologica",

issn = "1748-1708",

publisher = "Wiley-Blackwell",

number = "S711",

}

TY - JOUR

T1 - Modelling and drug screening for cardiovascular disease

AU - Passier, R.

PY - 2017/3

Y1 - 2017/3

N2 - Special Issue:Abstracts of the 96th Annual Meeting of the German Physiological Society, 16–18 March 2017, Greifswald, Germany

AB - Special Issue:Abstracts of the 96th Annual Meeting of the German Physiological Society, 16–18 March 2017, Greifswald, Germany

U2 - 10.1111/apha.12866

DO - 10.1111/apha.12866

M3 - Special issue

VL - 219

SP - 7

EP - 7

JO - Acta physiologica

JF - Acta physiologica

SN - 1748-1708

IS - S711

M1 - SO2-2

ER -

Modelling and drug screening for cardiovascular disease

Abstract

Access to Document

Fingerprint

Cite this